JJ
Jeffrey R Jay
10% Owner

Jeffrey R Jay insider trades: Adamas Pharmaceuticals (ADMS) stock buys and sales

10% Owner, Adamas Pharmaceuticals Last trade Jun 21, 2017 33 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
49
Open-market trades
since 2005
11
Companies
last trade 2017

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jeffrey reports to the SEC

and 5 more companies

Open-market buys and sales

49 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 21, 2017ADMS↓ Sell$6.5M
Dec 17, 2014CNXR↓ Sell$3.2M
Feb 10, 2011INFU↓ Sell$4.7M
Feb 10, 2011INFU↓ Sell$4.5M
Feb 10, 2011INFU↓ Sell$1.0M
Dec 8, 2008MEMY↓ Sell$13K
Dec 8, 2008MEMY↓ Sell$11K
Dec 5, 2008MEMY↓ Sell$311K
Dec 5, 2008MEMY↓ Sell$265K
Jul 8, 2008MEDE↓ Sell$1.6M
Jul 8, 2008MEDE↓ Sell$893K
Jul 1, 2008MEDE↑ Buy$1.1M
Nov 5, 2007MEMY↓ Sell$210K
Nov 5, 2007MEMY↓ Sell$179K
Oct 23, 2007MEMY↓ Sell$311K
Oct 22, 2007MEMY↓ Sell$265K
Oct 17, 2007MEMY↓ Sell$439K
Oct 17, 2007MEMY↓ Sell$374K
Oct 16, 2007MEMY↓ Sell$1.2M
Oct 16, 2007MEMY↓ Sell$958K
Jan 16, 2007ISPH↓ Sell$2.0M
Jan 16, 2007ISPH↓ Sell$1.7M
Jun 28, 2006ISPH↑ Buy$681K
Jun 28, 2006ISPH↑ Buy$629K
Mar 22, 2006AVM↓ Sell$6.6M
Mar 22, 2006AVM↓ Sell$6.1M
Mar 20, 2006AVM↓ Sell$1.7M
Mar 20, 2006AVM↓ Sell$1.7M
Mar 17, 2006AVM↓ Sell$122K
Mar 16, 2006AMV↓ Sell$965K
Mar 16, 2006AMV↓ Sell$917K
Mar 16, 2006AMV↓ Sell$460K
Mar 16, 2006AMV↓ Sell$399K
Mar 2, 2006AVM↓ Sell$558K
Mar 2, 2006AVM↓ Sell$515K
Feb 28, 2006AVM↓ Sell$885K
Feb 28, 2006AVM↓ Sell$147K
Feb 27, 2006AVM↓ Sell$62K
Feb 21, 2006AVM↓ Sell$750K
Aug 25, 2005PANC↓ Sell$685K
Aug 25, 2005PANC↓ Sell$685K
Aug 24, 2005PANC↓ Sell$1.0M
Aug 24, 2005PANC↓ Sell$1.0M
Aug 23, 2005PANC↓ Sell$15.8M
Aug 23, 2005PANC↓ Sell$6.6M
Jul 19, 2005VITX↓ Sell$1.7M
Jul 19, 2005VITX↓ Sell$1.7M
Jul 12, 2005VITX↓ Sell$4.0M
Jul 12, 2005VITX↓ Sell$4.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Jeffrey R Jay's insider trades

Jeffrey R Jay is a 10% owner of Adamas Pharmaceuticals (ADMS). Since Jul 12, 2005, Jeffrey has reported 3 open-market purchases worth $2.4M and 46 sales worth $89.4M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include other transactions (2 filings), option exercises (2 filings), gifts (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADMS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.